Baroda Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.65 M
as on 06-07-2024
- Company Age 56 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.95 M
as on 06-07-2024
- Revenue 108.53%
(FY 2023)
- Profit -10.53%
(FY 2023)
- Ebitda 36.05%
(FY 2023)
- Net Worth 14.30%
(FY 2023)
- Total Assets 31.66%
(FY 2023)
About Baroda Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.65 M.
The company currently has active open charges totaling ₹8.95 M.
Gopinath Saundararaman, Dineshchandra Patel, and Madhuraveliath Mohan serve as directors at the Company.
- CIN/LLPIN
U24231GJ1968ULT001525
- Company No.
001525
- Company Classification
Private Unlimited Liabilities Company
- Incorporation Date
20 Aug 1968
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Baroda Pharma Pvt Ltd offer?
Baroda Pharma Pvt Ltd offers a wide range of products and services, including Health Conditions, Fever.
Who are the key members and board of directors at Baroda Pharma?
Executive Team (1)
MM
Madhuraveliath Mohan
Managing DirectorAppointment Date: 05-Mar-2022
Status: Current
Board Members(2)
Financial Performance and Corporate Structure Insights of Baroda Pharma.
Baroda Pharma Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 108.53% increase. The company also saw a substantial fall in profitability, with a 10.53% decrease in profit. The company's net worth Soared by an impressive increase of 14.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baroda Pharma?
In 2023, Baroda Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
31 years 11 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Jul 2023 | ₹2.50 M | Open |
Indian Bank Creation Date: 27 Sep 2022 | ₹1.45 M | Open |
Pragati Sahakari Bank Limited Creation Date: 27 Dec 2006 | ₹3.00 M | Open |
How Many Employees Work at Baroda Pharma?
Baroda Pharma has a workforce of 32 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baroda Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baroda Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
